IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal
RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets hi...
Saved in:
Published in | Circulation research Vol. 111; no. 8; pp. 1054 - 1064 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Hagerstown, MD
American Heart Association, Inc
28.09.2012
Lippincott Williams & Wilkins |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect.
OBJECTIVE:We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal.
METHODS AND RESULTS:Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1.
CONCLUSIONS:In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest. |
---|---|
AbstractList | A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect.RATIONALEA high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect.We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal.OBJECTIVEWe investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal.Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1.METHODS AND RESULTSPostprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1.In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest.CONCLUSIONSIn response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest. A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect. We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal. Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1. In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest. RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process is monocyte recruitment through binding to vascular cell adhesion molecule 1 (VCAM-1) upregulated on inflamed arterial endothelium. Diets high in polyunsaturated fatty acids (PUFAs) may provide athero-protection by ameliorating this effect. OBJECTIVE:We investigated the acute regulation of VCAM-1 expression in human aortic endothelial cells (HAEC) in response to triglyceride-rich lipoproteins (TGRL) isolated from subjects after consumption of a high-fat meal. METHODS AND RESULTS:Postprandial TGRL isolated from 38 subjects were categorized as proatherogenic or antiatherogenic according to their capacity to alter the inflammatory response of HAEC. Proatherogenic TGRL increased expression of VCAM-1, intercellular adhesion molecule 1 (ICAM-1), and E-selectin by ≈20% compared with stimulation with tumor necrosis factor-α alone, whereas antiatherogenic TGRL decreased VCAM-1 expression by ≈20% while still upregulating ICAM-1. The relative atherogenicity of TGRL positively correlated with particle density of TG, apolipoprotein (Apo)CIII, ApoE, and cholesterol. Ω3-PUFA mimicked the effect of antiatherogenic TGRL by downregulating VCAM-1 expression. TGRL exerted this differential regulation of VCAM-1 by reciprocally modulating expression and activity of the transcription factor interferon regulatory factor 1 (IRF-1) and expression of microRNA 126 (miR-126). Overexpression or silencing of IRF-1 or miR-126 expression recapitulated the proatherogenic or antiatherogenic regulation of VCAM-1. CONCLUSIONS:In response to a high-fat meal, TGRL bias the inflammatory response of endothelium via transcriptional and posttranscriptional editing of VCAM-1. Subjects with an anti-inflammatory response to a meal produced TGRL that was enriched in nonesterified fatty acids, decreased IRF-1 expression, increased miR-126 activity, and diminished monocyte arrest. |
Author | Wang, Ying I. Radecke, Christopher E. Armstrong, Ehrin J. Edwards, Christina M. Foster, Greg A. Alkhoury, Kenan Facciotti, Marc T. Newman, John W. Passerini, Anthony G. Knowlton, Anne A. Simon, Scott I. Sun, Chongxiu Tam, Kayan |
AuthorAffiliation | From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.) |
AuthorAffiliation_xml | – name: From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.) – name: 5 Obesity and Metabolism Research Unit, USDA-ARS- Western Human Nutrition Research Center, Davis, CA – name: 2 Division of Cardiovascular Medicine, University of California Davis, Davis CA – name: 3 Departments of Medicine and Pharmacology, University of California Davis, Davis CA – name: 4 Department of Nutrition, University of California Davis, Davis CA – name: 1 Department of Biomedical Engineering, University of California Davis, Davis CA |
Author_xml | – sequence: 1 givenname: Chongxiu surname: Sun fullname: Sun, Chongxiu organization: From the Department of Biomedical Engineering (C.S., K.A., Y.I.W., G.A.F., C.E.R., K.T., C.M.E., M.T.F., A.G.P., S.I.S.), the Division of Cardiovascular Medicine (E.J.A.), the Departments of Medicine and Pharmacology (A.A.K.), and the Department of Nutrition (J.W.N.), University of California Davis, Davis CA; and Obesity and Metabolism Research Unit, USDA-ARS–Western Human, Nutrition Research Center, Davis, CA (J.W.N.) – sequence: 2 givenname: Kenan surname: Alkhoury fullname: Alkhoury, Kenan – sequence: 3 givenname: Ying surname: Wang middlename: I. fullname: Wang, Ying I. – sequence: 4 givenname: Greg surname: Foster middlename: A. fullname: Foster, Greg A. – sequence: 5 givenname: Christopher surname: Radecke middlename: E. fullname: Radecke, Christopher E. – sequence: 6 givenname: Kayan surname: Tam fullname: Tam, Kayan – sequence: 7 givenname: Christina surname: Edwards middlename: M. fullname: Edwards, Christina M. – sequence: 8 givenname: Marc surname: Facciotti middlename: T. fullname: Facciotti, Marc T. – sequence: 9 givenname: Ehrin surname: Armstrong middlename: J. fullname: Armstrong, Ehrin J. – sequence: 10 givenname: Anne surname: Knowlton middlename: A. fullname: Knowlton, Anne A. – sequence: 11 givenname: John surname: Newman middlename: W. fullname: Newman, John W. – sequence: 12 givenname: Anthony surname: Passerini middlename: G. fullname: Passerini, Anthony G. – sequence: 13 givenname: Scott surname: Simon middlename: I. fullname: Simon, Scott I. |
BackLink | http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=26395633$$DView record in Pascal Francis https://www.ncbi.nlm.nih.gov/pubmed/22874466$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV9v0zAUxS00xLrBRwD5BYmXDDtxnFhISFXU0kotSOHPq-XYN6vBjTs7YfDtMWrHgJc9WVf3d-6xzrlAZ4MfAKHnlFxRyunrZt027eLjfDVPc36VV6Sg7BGa0TJnGSsreoZmhBCRVUVBztFFjF8JoazIxRN0nud1xRjnM7RZt8uMYjUYvLft-znNOd56Mzk1Av7SzLdpufhxCBCj9QO2A24hHvwQAY8eK7yy17tsqUa8BeWeose9chGend5L9Hm5-NSsss2Hd-tmvsl0SQnLoNK0r0Qtur4WzPCSAy1VBXVlBPCKaSBGGVMIVppeM02rTkBfm7LrTK0ELS7R2-Pdw9TtwWgYxqCcPAS7V-Gn9MrKfzeD3clr_10WNSWUl-nAq9OB4G8miKPc26jBOTWAn6KkpKYpoZRzQl_87fXH5C7CBLw8ASpq5fqgBm3jPccLUfKiSNybI6eDjzFAL7Ud1ZhSTV-0LnnK38XK-2LTnMtjsUld_qe-M3hIJ466W-9GCPGbm24hyF1qa9w9oP0F8Q23QA |
CODEN | CIRUAL |
CitedBy_id | crossref_primary_10_1096_fj_14_260323 crossref_primary_10_1186_s12860_021_00345_x crossref_primary_10_1002_stem_2193 crossref_primary_10_1016_j_jnutbio_2019_03_004 crossref_primary_10_1007_s10557_021_07168_0 crossref_primary_10_1016_j_lfs_2015_04_016 crossref_primary_10_1186_1471_2377_13_178 crossref_primary_10_1152_ajpheart_00411_2018 crossref_primary_10_1084_jem_20131125 crossref_primary_10_1097_SLA_0000000000001466 crossref_primary_10_1152_ajpheart_00311_2013 crossref_primary_10_1016_j_jnutbio_2015_07_012 crossref_primary_10_3389_fendo_2021_646233 crossref_primary_10_1038_s41598_019_45005_5 crossref_primary_10_1097_MOL_0000000000000108 crossref_primary_10_14336_AD_2021_0929 crossref_primary_10_3390_jcm8122199 crossref_primary_10_1186_s12944_017_0625_0 crossref_primary_10_1016_j_jstrokecerebrovasdis_2021_106292 crossref_primary_10_3389_fmolb_2022_909151 crossref_primary_10_1007_s12031_013_0207_1 crossref_primary_10_1097_CRD_0000000000000114 crossref_primary_10_1007_s11883_022_00979_y crossref_primary_10_1161_HYPERTENSIONAHA_115_04898 crossref_primary_10_1089_ars_2012_4803 crossref_primary_10_1016_j_mce_2017_05_039 crossref_primary_10_1097_HCO_0b013e3283606971 crossref_primary_10_3390_jfb16010002 crossref_primary_10_1177_20503121241272646 crossref_primary_10_1016_j_expneurol_2020_113382 crossref_primary_10_1111_cmi_12819 crossref_primary_10_1194_jlr_M067108 crossref_primary_10_1152_physiolgenomics_00106_2013 crossref_primary_10_1186_s13104_021_05700_x crossref_primary_10_1055_a_1480_7692 crossref_primary_10_1161_ATVBAHA_115_306094 crossref_primary_10_1536_ihj_17_459 crossref_primary_10_1002_biof_1306 crossref_primary_10_1161_CIRCRESAHA_115_307674 crossref_primary_10_1007_s10753_024_02209_w crossref_primary_10_3390_nu11061326 crossref_primary_10_3389_fcvm_2022_889743 crossref_primary_10_1016_j_plefa_2018_05_001 crossref_primary_10_3390_cells11040607 crossref_primary_10_1016_j_cpcardiol_2019_03_002 crossref_primary_10_1016_j_yjmcc_2016_12_005 crossref_primary_10_1016_j_biopha_2025_117953 crossref_primary_10_1016_j_lfs_2013_08_010 crossref_primary_10_1093_cvr_cvv192 crossref_primary_10_1080_07315724_2021_2025168 crossref_primary_10_1371_journal_pone_0215620 crossref_primary_10_18632_oncotarget_25542 crossref_primary_10_1146_annurev_bioeng_071813_104908 crossref_primary_10_1093_jn_nxaa003 crossref_primary_10_1080_21655979_2022_2063496 crossref_primary_10_1007_s10571_016_0331_x crossref_primary_10_1167_iovs_18_25617 crossref_primary_10_1007_s12170_022_00702_1 crossref_primary_10_3389_fimmu_2022_1097409 crossref_primary_10_1007_s11883_013_0372_2 crossref_primary_10_18632_oncotarget_2280 crossref_primary_10_4049_jimmunol_2000485 crossref_primary_10_1111_ejn_12872 crossref_primary_10_1016_j_jacc_2014_09_042 crossref_primary_10_3390_pharmaceutics15051379 crossref_primary_10_1038_s41598_017_08417_9 crossref_primary_10_5301_heartint_5000226 crossref_primary_10_1016_j_jacbts_2022_08_002 crossref_primary_10_1161_JAHA_114_001249 crossref_primary_10_1080_01616412_2017_1327505 |
Cites_doi | 10.1046/j.1365-2796.1999.00548.x 10.1194/jlr.M010371 10.1161/circulationaha.106.622514 10.1128/MCB.15.5.2558 10.1093/ajcn/83.2.456S 10.4049/jimmunol.180.11.7516 10.1073/pnas.0707493105 10.1161/01.ATV.21.3.407 10.1093/ajcn/81.1.25 10.1038/nri2156 10.1016/j.plefa.2007.10.004 10.1152/ajpheart.01036.2010 10.1084/jem.187.12.2023 10.4049/jimmunol.173.3.2041 10.1074/jbc.270.48.28903 10.1084/jem.176.6.1583 10.1161/atvbaha.110.211706 10.1016/j.jnutbio.2010.01.007 10.1161/01.res.0000258023.76515.a3 10.1021/ac050692f 10.1073/pnas.0538015100 10.1097/00007890-200005270-00030 10.1161/atvbaha.110.215434 10.1016/j.cell.2008.07.048 10.1016/S1097-2765(00)80467-0 10.1111/j.1365-2567.2008.02892.x 10.1016/j.metabol.2008.01.036 10.1042/BST0320994 10.1161/01.CIR.99.24.3125 10.1007/s00394-003-0408-4 10.1161/CIR.0b013e3182160726 10.1161/atvbaha.107.159228 10.1074/jbc.M109.044065 10.1093/ajcn/71.1.213S 10.1016/S0002-9149(96)00760-6 10.1194/jlr.M700505-JLR200 10.4049/jimmunol.0902369 10.1016/j.numecd.2008.07.008 |
ContentType | Journal Article |
Copyright | 2012 American Heart Association, Inc. 2015 INIST-CNRS |
Copyright_xml | – notice: 2012 American Heart Association, Inc. – notice: 2015 INIST-CNRS |
DBID | AAYXX CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
DOI | 10.1161/CIRCRESAHA.112.270314 |
DatabaseName | CrossRef Pascal-Francis Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
DatabaseTitleList | MEDLINE - Academic MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1524-4571 |
EndPage | 1064 |
ExternalDocumentID | PMC3810165 22874466 26395633 10_1161_CIRCRESAHA_112_270314 10.1161/CIRCRESAHA.112.270314 |
Genre | Research Support, U.S. Gov't, Non-P.H.S Journal Article Research Support, N.I.H., Extramural |
GrantInformation_xml | – fundername: NHLBI NIH HHS grantid: HL077281 – fundername: NIAID NIH HHS grantid: R01 AI047294 – fundername: NCI NIH HHS grantid: P30 CA093373 – fundername: NHLBI NIH HHS grantid: R01 HL082689 – fundername: NHLBI NIH HHS grantid: HL082689 – fundername: NHLBI NIH HHS grantid: R01 HL077281 – fundername: NHLBI NIH HHS grantid: R01 HL079071 – fundername: NHLBI NIH HHS grantid: HL079071 – fundername: National Heart, Lung, and Blood Institute : NHLBI grantid: R01 HL082689 || HL |
GroupedDBID | --- -~X .-D .3C .55 .GJ .Z2 01R 0R~ 18M 1CY 1J1 29B 2WC 40H 41~ 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AARTV AASCR AASOK AAXQO ABASU ABBUW ABDIG ABJNI ABOCM ABPXF ABQRW ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACILI ACLDA ACNWC ACPRK ACWDW ACWRI ACXJB ACXNZ ACZKN ADBBV ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AGINI AHMBA AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BAWUL BOYCO BQLVK BS7 BYPQX C1A C45 CS3 DIK DIWNM DU5 DUNZO E.X E3Z EBS EEVPB EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FRP FW0 GNXGY GQDEL GX1 H0~ H13 HLJTE HZ~ H~9 IKREB IKYAY IN~ IPNFZ J5H JF9 JG8 JK3 JK8 K8S KD2 KMI KQ8 L-C L7B MVM N9A N~7 N~B N~M O9- OAG OAH OB2 OCUKA ODA OK1 OL1 OLG OLH OLU OLV OLY OLZ OPUJH ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P PQQKQ R58 RAH RIG RLZ S4R S4S T8P TEORI TR2 TSPGW UPT V2I VVN W3M W8F WH7 WOQ WOW X3V X3W X7M XXN XYM YFH YOC ZFV ZGI ZZMQN AAYXX ADGHP CITATION IQODW CGR CUY CVF ECM EIF NPM 7X8 5PM |
ID | FETCH-LOGICAL-c5104-e7c1f7989bf894d656e15a7e87d9e674ce0dadd3945dfc4c17b9ef8d5bbd8a913 |
ISSN | 0009-7330 1524-4571 |
IngestDate | Thu Aug 21 14:02:13 EDT 2025 Thu Jul 10 23:24:52 EDT 2025 Mon Jul 21 06:06:38 EDT 2025 Mon Jul 21 09:14:52 EDT 2025 Tue Jul 01 04:27:43 EDT 2025 Thu Apr 24 23:05:21 EDT 2025 Fri May 16 03:47:18 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 8 |
Keywords | Metabolic diseases Cardiovascular disease Lipids Hyperlipoproteinemia Lipoprotein triglycerides Triglyceride Enzymopathy Fatty acids Vascular disease Vertebrata Mammalia Hypertriglyceridemia Atherosclerosis Fat Endothelial dysfunction Circulatory system Dyslipemia |
Language | English |
License | CC BY 4.0 |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c5104-e7c1f7989bf894d656e15a7e87d9e674ce0dadd3945dfc4c17b9ef8d5bbd8a913 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
PMID | 22874466 |
PQID | 1081874161 |
PQPubID | 23479 |
PageCount | 11 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_3810165 proquest_miscellaneous_1081874161 pubmed_primary_22874466 pascalfrancis_primary_26395633 crossref_citationtrail_10_1161_CIRCRESAHA_112_270314 crossref_primary_10_1161_CIRCRESAHA_112_270314 wolterskluwer_health_10_1161_CIRCRESAHA_112_270314 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2012-09-28 |
PublicationDateYYYYMMDD | 2012-09-28 |
PublicationDate_xml | – month: 09 year: 2012 text: 2012-09-28 day: 28 |
PublicationDecade | 2010 |
PublicationPlace | Hagerstown, MD |
PublicationPlace_xml | – name: Hagerstown, MD – name: United States |
PublicationTitle | Circulation research |
PublicationTitleAlternate | Circ Res |
PublicationYear | 2012 |
Publisher | American Heart Association, Inc Lippincott Williams & Wilkins |
Publisher_xml | – name: American Heart Association, Inc – name: Lippincott Williams & Wilkins |
References | e_1_3_4_3_2 e_1_3_4_2_2 e_1_3_4_9_2 e_1_3_4_8_2 e_1_3_4_7_2 e_1_3_4_41_2 e_1_3_4_6_2 e_1_3_4_40_2 e_1_3_4_5_2 e_1_3_4_4_2 e_1_3_4_22_2 e_1_3_4_23_2 e_1_3_4_20_2 e_1_3_4_21_2 e_1_3_4_26_2 e_1_3_4_27_2 e_1_3_4_24_2 e_1_3_4_25_2 e_1_3_4_28_2 e_1_3_4_29_2 Hart CM (e_1_3_4_32_2) 1991; 260 Grapov D (e_1_3_4_16_2) e_1_3_4_30_2 e_1_3_4_11_2 e_1_3_4_34_2 e_1_3_4_12_2 e_1_3_4_33_2 e_1_3_4_10_2 e_1_3_4_31_2 e_1_3_4_15_2 e_1_3_4_38_2 e_1_3_4_37_2 e_1_3_4_13_2 e_1_3_4_36_2 e_1_3_4_14_2 e_1_3_4_35_2 e_1_3_4_19_2 e_1_3_4_17_2 e_1_3_4_18_2 e_1_3_4_39_2 7499419 - J Biol Chem. 1995 Dec 1;270(48):28903-9 19648648 - J Biol Chem. 2009 Oct 2;284(40):27384-92 20573493 - J Nutr Biochem. 2011 Feb;22(2):187-94 10583705 - J Intern Med. 1999 Oct;246(4):341-55 2058691 - Am J Physiol. 1991 Jun;260(6 Pt 1):L481-8 9625761 - J Exp Med. 1998 Jun 15;187(12):2023-30 18490752 - J Immunol. 2008 Jun 1;180(11):7516-24 18036803 - Prostaglandins Leukot Essent Fatty Acids. 2008 Jan;78(1):33-43 17717539 - Nat Rev Immunol. 2007 Sep;7(9):678-89 7537851 - Mol Cell Biol. 1995 May;15(5):2558-69 19949084 - J Immunol. 2010 Jan 1;184(1):21-5 22815358 - Bioinformatics. 2012 Sep 1;28(17):2288-90 10617974 - Am J Clin Nutr. 2000 Jan;71(1 Suppl):213S-23S 16159116 - Anal Chem. 2005 Sep 15;77(18):5870-6 18624726 - Immunology. 2009 Feb;126(2):233-45 15506945 - Biochem Soc Trans. 2004 Dec;32(Pt 6):994-8 15265939 - J Immunol. 2004 Aug 1;173(3):2041-9 21502576 - Circulation. 2011 May 24;123(20):2292-333 18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49 20852092 - J Lipid Res. 2010 Dec;51(12):3470-80 1281211 - J Exp Med. 1992 Dec 1;176(6):1583-93 9036757 - Am J Cardiol. 1997 Feb 1;79(3):350-4 21169396 - Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H784-91 20671229 - Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1990-7 12923654 - Eur J Nutr. 2003 Aug;42(4):224-7 17234968 - Circ Res. 2007 Feb 16;100(3):381-90 16894036 - Circulation. 2006 Aug 15;114(7):681-7 10198642 - Mol Cell. 1999 Mar;3(3):397-403 16470012 - Am J Clin Nutr. 2006 Feb;83(2):456S-460S 18803934 - Metabolism. 2008 Oct;57(10):1328-39 21030716 - Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6 12606719 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2730-5 18812596 - J Lipid Res. 2009 Feb;50(2):204-13 10377075 - Circulation. 1999 Jun 22;99(24):3125-31 18805087 - Cell. 2008 Sep 19;134(6):933-44 18227515 - Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21 18804984 - Nutr Metab Cardiovasc Dis. 2009 May;19(4):264-70 11231921 - Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):407-14 15640456 - Am J Clin Nutr. 2005 Jan;81(1):25-34 10852612 - Transplantation. 2000 May 27;69(10):2131-7 |
References_xml | – ident: e_1_3_4_2_2 doi: 10.1046/j.1365-2796.1999.00548.x – ident: e_1_3_4_31_2 doi: 10.1194/jlr.M010371 – ident: e_1_3_4_16_2 article-title: Imdev: a graphical user interface to r multivariate analysis tools in Microsoft Excel. publication-title: Bioinformatics – ident: e_1_3_4_10_2 doi: 10.1161/circulationaha.106.622514 – ident: e_1_3_4_38_2 doi: 10.1128/MCB.15.5.2558 – ident: e_1_3_4_17_2 doi: 10.1093/ajcn/83.2.456S – ident: e_1_3_4_20_2 doi: 10.4049/jimmunol.180.11.7516 – ident: e_1_3_4_22_2 doi: 10.1073/pnas.0707493105 – ident: e_1_3_4_24_2 doi: 10.1161/01.ATV.21.3.407 – ident: e_1_3_4_7_2 doi: 10.1093/ajcn/81.1.25 – ident: e_1_3_4_11_2 doi: 10.1038/nri2156 – ident: e_1_3_4_36_2 doi: 10.1016/j.plefa.2007.10.004 – ident: e_1_3_4_13_2 doi: 10.1152/ajpheart.01036.2010 – ident: e_1_3_4_21_2 doi: 10.1084/jem.187.12.2023 – ident: e_1_3_4_15_2 doi: 10.4049/jimmunol.173.3.2041 – ident: e_1_3_4_39_2 doi: 10.1074/jbc.270.48.28903 – ident: e_1_3_4_19_2 doi: 10.1084/jem.176.6.1583 – ident: e_1_3_4_41_2 doi: 10.1161/atvbaha.110.211706 – ident: e_1_3_4_37_2 doi: 10.1016/j.jnutbio.2010.01.007 – ident: e_1_3_4_12_2 doi: 10.1161/01.res.0000258023.76515.a3 – ident: e_1_3_4_6_2 doi: 10.1021/ac050692f – ident: e_1_3_4_25_2 doi: 10.1073/pnas.0538015100 – ident: e_1_3_4_40_2 doi: 10.1097/00007890-200005270-00030 – ident: e_1_3_4_14_2 doi: 10.1161/atvbaha.110.215434 – ident: e_1_3_4_30_2 doi: 10.1016/j.cell.2008.07.048 – volume: 260 start-page: L481 year: 1991 ident: e_1_3_4_32_2 article-title: Supplemental fatty acids alter lipid peroxidation and oxidant injury in endothelial cells. publication-title: Am J Physiol – ident: e_1_3_4_26_2 doi: 10.1016/S1097-2765(00)80467-0 – ident: e_1_3_4_29_2 doi: 10.1111/j.1365-2567.2008.02892.x – ident: e_1_3_4_34_2 doi: 10.1016/j.metabol.2008.01.036 – ident: e_1_3_4_8_2 doi: 10.1042/BST0320994 – ident: e_1_3_4_28_2 doi: 10.1161/01.CIR.99.24.3125 – ident: e_1_3_4_33_2 doi: 10.1007/s00394-003-0408-4 – ident: e_1_3_4_3_2 doi: 10.1161/CIR.0b013e3182160726 – ident: e_1_3_4_5_2 doi: 10.1161/atvbaha.107.159228 – ident: e_1_3_4_27_2 doi: 10.1074/jbc.M109.044065 – ident: e_1_3_4_18_2 doi: 10.1093/ajcn/71.1.213S – ident: e_1_3_4_4_2 doi: 10.1016/S0002-9149(96)00760-6 – ident: e_1_3_4_9_2 doi: 10.1194/jlr.M700505-JLR200 – ident: e_1_3_4_23_2 doi: 10.4049/jimmunol.0902369 – ident: e_1_3_4_35_2 doi: 10.1016/j.numecd.2008.07.008 – reference: 17717539 - Nat Rev Immunol. 2007 Sep;7(9):678-89 – reference: 2058691 - Am J Physiol. 1991 Jun;260(6 Pt 1):L481-8 – reference: 20671229 - Arterioscler Thromb Vasc Biol. 2010 Oct;30(10):1990-7 – reference: 15506945 - Biochem Soc Trans. 2004 Dec;32(Pt 6):994-8 – reference: 7537851 - Mol Cell Biol. 1995 May;15(5):2558-69 – reference: 10377075 - Circulation. 1999 Jun 22;99(24):3125-31 – reference: 10583705 - J Intern Med. 1999 Oct;246(4):341-55 – reference: 21169396 - Am J Physiol Heart Circ Physiol. 2011 Mar;300(3):H784-91 – reference: 19648648 - J Biol Chem. 2009 Oct 2;284(40):27384-92 – reference: 18812596 - J Lipid Res. 2009 Feb;50(2):204-13 – reference: 18356555 - Arterioscler Thromb Vasc Biol. 2008 Jun;28(6):1039-49 – reference: 18804984 - Nutr Metab Cardiovasc Dis. 2009 May;19(4):264-70 – reference: 21502576 - Circulation. 2011 May 24;123(20):2292-333 – reference: 18805087 - Cell. 2008 Sep 19;134(6):933-44 – reference: 11231921 - Arterioscler Thromb Vasc Biol. 2001 Mar;21(3):407-14 – reference: 19949084 - J Immunol. 2010 Jan 1;184(1):21-5 – reference: 20852092 - J Lipid Res. 2010 Dec;51(12):3470-80 – reference: 16894036 - Circulation. 2006 Aug 15;114(7):681-7 – reference: 18490752 - J Immunol. 2008 Jun 1;180(11):7516-24 – reference: 21030716 - Arterioscler Thromb Vasc Biol. 2011 Jan;31(1):160-6 – reference: 10198642 - Mol Cell. 1999 Mar;3(3):397-403 – reference: 9625761 - J Exp Med. 1998 Jun 15;187(12):2023-30 – reference: 15265939 - J Immunol. 2004 Aug 1;173(3):2041-9 – reference: 16159116 - Anal Chem. 2005 Sep 15;77(18):5870-6 – reference: 18803934 - Metabolism. 2008 Oct;57(10):1328-39 – reference: 10617974 - Am J Clin Nutr. 2000 Jan;71(1 Suppl):213S-23S – reference: 20573493 - J Nutr Biochem. 2011 Feb;22(2):187-94 – reference: 22815358 - Bioinformatics. 2012 Sep 1;28(17):2288-90 – reference: 17234968 - Circ Res. 2007 Feb 16;100(3):381-90 – reference: 12606719 - Proc Natl Acad Sci U S A. 2003 Mar 4;100(5):2730-5 – reference: 1281211 - J Exp Med. 1992 Dec 1;176(6):1583-93 – reference: 9036757 - Am J Cardiol. 1997 Feb 1;79(3):350-4 – reference: 18036803 - Prostaglandins Leukot Essent Fatty Acids. 2008 Jan;78(1):33-43 – reference: 10852612 - Transplantation. 2000 May 27;69(10):2131-7 – reference: 12923654 - Eur J Nutr. 2003 Aug;42(4):224-7 – reference: 7499419 - J Biol Chem. 1995 Dec 1;270(48):28903-9 – reference: 18624726 - Immunology. 2009 Feb;126(2):233-45 – reference: 15640456 - Am J Clin Nutr. 2005 Jan;81(1):25-34 – reference: 18227515 - Proc Natl Acad Sci U S A. 2008 Feb 5;105(5):1516-21 – reference: 16470012 - Am J Clin Nutr. 2006 Feb;83(2):456S-460S |
SSID | ssj0014329 |
Score | 2.3838494 |
Snippet | RATIONALE:A high-fat diet accompanied by hypertriglyceridemia increases an individual’s risk for development of atherosclerosis. An early event in this process... A high-fat diet accompanied by hypertriglyceridemia increases an individual's risk for development of atherosclerosis. An early event in this process is... |
SourceID | pubmedcentral proquest pubmed pascalfrancis crossref wolterskluwer |
SourceType | Open Access Repository Aggregation Database Index Database Enrichment Source Publisher |
StartPage | 1054 |
SubjectTerms | Aorta - cytology Atherosclerosis (general aspects, experimental research) Atherosclerosis - genetics Atherosclerosis - metabolism Biological and medical sciences Blood and lymphatic vessels Cardiology. Vascular system Cell Adhesion - physiology Cell Line Dietary Fats - administration & dosage Dietary Fats, Unsaturated - administration & dosage Disorders of blood lipids. Hyperlipoproteinemia Endothelial Cells - cytology Endothelial Cells - physiology Fundamental and applied biological sciences. Psychology Humans Hypertriglyceridemia - genetics Hypertriglyceridemia - metabolism Interferon Regulatory Factor-1 - genetics Interferon Regulatory Factor-1 - metabolism Medical sciences Metabolic diseases MicroRNAs - physiology Monocytes - metabolism NF-kappa B - metabolism Postprandial Period - physiology Protein Processing, Post-Translational - physiology Transcription Factor AP-1 - metabolism Tumor Necrosis Factor-alpha - metabolism Vascular Cell Adhesion Molecule-1 - genetics Vascular Cell Adhesion Molecule-1 - metabolism Vertebrates: cardiovascular system |
Title | IRF-1 and miRNA126 Modulate VCAM-1 Expression in Response to a High-Fat Meal |
URI | https://www.ncbi.nlm.nih.gov/pubmed/22874466 https://www.proquest.com/docview/1081874161 https://pubmed.ncbi.nlm.nih.gov/PMC3810165 |
Volume | 111 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKkBDShLgTLpOReKtS6tRxkseoWulQW6TSQnmKEsdh1dZkWhMx8es5duykFRUMXqLWqXPp9_n4-PhcEHpHWTxwYy53GFnfptIpxxeM2CkRjidThPUzadCfzth4ST-u3FWnM9nxWqrKpMd_Howr-R9UoQ1wlVGy_4Bsc1FogM-ALxwBYTjeCuOz-cgmyvy_Wc9nIQEUN0UqC3KJ7pdhOIWT4kZ7uuZ15IryiFXlMuKuTFVsZ3HZ3Qh9J5OyYH3NdVmvrs4G1FiNP1d6m77Iv9-sq4Ywlxfnhd6TB-Hdcu6rNkh_U64J7aRnKoLIIBltUNXGB-nFEZhgbi0vHWpTt66i0hMH2oyQ1SK1ZpO_IzJBwaOHZTmTsnx4Nh8CF8NxKKOdeo7Kt99OXmbDfvYpGi0nk2hxulrcQXcdWDTIehYfVo3DDyiGqmZd83g6ngtu8_7gTfY0leOreAuDJqurnRxajvzuVXv8o5AeD9sLFfCwo7YsHqIHer2Bw5o8j1BH5I_Rvan2qHiCJopDGDiEDYew4RCuOYRbDuF1jg2HcFngGBsOYcmhp2g5Ol0Mx7ausGFzkMXUFh4nmQcDNMn8gKag2wvixp7wvTQQzKNc9FOYAAcBddOMU068JBCZn7pJkvpxQAbP0FFe5OIFwgImBof0U1DAM5rwLCEOj_vczTw3gTW8sBA1_2bEdfp5WQXlMlLLUEaiFgT47kQ1CBbqNd2u6vwrf-twsgdV08sBXdxlg4GF3hrsIhClcn8szkVRbWWuXFmhEi5toec1lm1vVSeCMQt5eyg3P5Bp2vfP5Otzla5d5dBjroWcPT5EdaDzn9_m5S0e9hW63w7N1-iovK7EG9CUy-REDYBf73e2qQ |
linkProvider | Geneva Foundation for Medical Education and Research |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=IRF-1+and+miRNA126+modulate+VCAM-1+expression+in+response+to+a+high-fat+meal&rft.jtitle=Circulation+research&rft.au=Sun%2C+Chongxiu&rft.au=Alkhoury%2C+Kenan&rft.au=Wang%2C+Ying+I&rft.au=Foster%2C+Greg+A&rft.date=2012-09-28&rft.issn=1524-4571&rft.eissn=1524-4571&rft.volume=111&rft.issue=8&rft.spage=1054&rft_id=info:doi/10.1161%2FCIRCRESAHA.112.270314&rft.externalDBID=NO_FULL_TEXT |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0009-7330&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0009-7330&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0009-7330&client=summon |